Colour enhancement

From PsychonautWiki
Jump to navigation Jump to search

Colour enhancement is defined as an intensification of the brightness and vividness of colors in the external environment. During this experience, reds may seem “redder”, greens may seem “greener", and all colors will likely appear much more distinct, complex, and visually intense than they comparatively would be during everyday sober living.[1][2][3][4][5][6][7][8] At higher levels, this effect can sometimes result in seeing colours which are perceived as surreal or seemingly impossible.[3][4]

Colour enhancement is often accompanied by other coinciding effects such as acuity enhancement and pattern recognition enhancement.[1][2] It is most commonly induced under the influence of mild dosages of psychedelic compounds, such as LSD, psilocybin, and mescaline. However, it can also occur to a lesser extent under the influence of certain stimulants and dissociatives such as MDMA, ketamine[9], or 3-MeO-PCP.

Image examples

 Caption
Experience:75mg 3-FMA - Perfect Blend of Euphoria and Functionality
THJ-2201
Efavirenz
Phenylpiracetam
2C-I
3C-E
Oxiracetam
Experience:300mg DXM + 25mg DMT + Cannabis - A crazy night
Experience:225mg Pregabalin +Cannabis -Bliss and Serenity; a hedonistic evening
4-HO-EPT
Experience:3 Grams of Mushrooms - Reset on my Life, Experiencing Satori and the Cosmic Perspective
2C-T-2
Enhancement of colour rose.jpgRose by Chelsea Morgan
Escaline
JWH-018
1P-LSD
Paradise island by Xanny.jpgParadise island by Subsentience
MET
25C-NBOMe
Experience:4.5g - The Grand Introduction to Beauty and Fear
Experience:250mg DXM - DXM Itch and Trip Report
4-HO-DPT
4-HO-MPT
Amanita muscaria
Experience:5.3g psilocybe cubensis - Dimensional Circumstance and the Fabric of Understanding
THJ-018
4-HO-MET
Ayahuasca
Experience:1050 µg 1cP-LSD - The matrix
Experience:60mg 4-AcO-DMT Nonstop Quasi-Orgasmic Objectless Euphoria
2C-P
4-FA
MDAI
Memantine
Experience:150mg MDMA + 20mg 2C-B - I designed it this way myself
25B-NBOH
Experience:Unknown dosage / 1 tab DOC - Psychedelia Turned Into Stimulant Psychosis
DET
4-AcO-DMT
Coluracetam
Experience: 22mg 2C-B (oral) / 100ug 1P-LSD (sublingual) - My first time tripping alone (2 days in a row)
25I-NBOH
Experience:3.5g psilocybe cubensis - Relinquishing of Material Chains/Fear and Desolation
MiPLA
TMA-6
Experience:40mg - Brothermind and the Forest's Hand
MPT
ALD-52
LSM-775
ΑMT
4-HO-DET
Experience:BK-2C-B - Various experiences
MiPT
ETH-LAD
Tree.jpgJapanese Garden by Anonymous
LSA
Βk-2C-B
Experience:Unknown Dose DOC (Insufflated) - Overdosing and Terifying Ego Death
Piracetam
5-MeO-DiPT
Experience:120mg - Garden of The Gods
Experience:337mg DMT fumarate - A Day With DMT
Chur City in Switzerland.jpgChur, Switzerland by Naps284
GABAergic hallucinogens
Experience:1000 Morning Glory seeds - Rediscovering the Self
Experience:A combination of DOC, 5-MAPB, 5-MeO-DMT, ETH-LAD, Cannabis, Pentedrone
TMA-2
Experience:4x 200ug tabs - You do not need to understand
5F-PB-22
2C-C
Enhancementofcolour.jpgShowing differences by Chelsea Morgan
1B-LSD
Mescaline
LSD
Experience:4-HO-MiPT / A care free psychedelic getaway
MDEA
6-APB
Omberacetam
2C-D
AL-LAD
Experience: 5-EAPB (60mg) + 2-FMA (20mg) + 4-AcO-DMT (10mg) - Emotional catharsis
Pramiracetam
Experience: 15mg 2C-B (oral) - A pleasant low-dose evening with Nexus
Bufotenin
5-Hydroxytryptophan
Enhancement of colours - woods.jpgThe Woods by Chelsea Morgan
PRO-LAD
Experience:2.5g Syrian rue + 6g Mimosa Hostilis - Becoming God (my second experience with unity)
EPT
Experience:2 tabs DOB - My DOB Nightmare
Proscaline
Psilocybin mushrooms
Experience:1mg 25c-NBOMe - Experiment in my room
DiPT
Experience: 36mg 4-AcO-DiPT - Truly, one for the psychedelic animals among us
4-AcO-DiPT
JWH-073
Experience:Mushrooms and Snuff Films -- Trip Report (3.5 grams)
Experience:300µg AL-LAD - Don't worry, because you're everyone!
Experience:3-MeO-PCP - Extreme psychosis
Experience:25mg Deschloroketamine - My first time orally dosing DCK
5-MeO-DALT
Allylescaline
DOC
2C-H
LSZ
Psilocin
Ibogaine
Methallylescaline
25N-NBOMe
DOI
Experience:800 seeds LSA - My First Trip Ever
2C-E
1P-ETH-LAD
Experience:4-AcO-DMT + 200mg Pill
Chameleon.jpgChameleon by Anonymous.
Experience:3g mimosa / 3g syrian rue - Connecting with my body
3-MMC
Selective serotonin reuptake inhibitor
2C-T-21
Pregabalin
DOM
5-MeO-MiPT
4-AcO-MET
PARGY-LAD
2C-B-FLY
Experience:225ug LSD + 9g cubensis - Galactic Melt and the Meverse
DOB
25C-NBOH
6-APDB
5-MeO-DiBF
4-HO-DiPT
3-MeO-PCE
MDMA
Experience:300µg LSD - Togetherness and the Silent Dusk
25D-NBOMe
4-HO-MiPT
25I-NBOMe
Bromo-DragonFLY
Experience:2C-P (approx. 35mg) - Asymmetrical Terror and the Geometric Sea
25B-NBOMe
2C-T-7
DMT
MDA
Experience:25mg 3-MeO-PCP - Enhanced film experience
Aniracetam
2C-B
4-AcO-MiPT
Phenethylamine (compound)
Experience:~150mg MDA(oral) - a case of mistaken identity
DPT
4-AcO-DET

Psychoactive substances

Compounds within our psychoactive substance index which may cause this effect include:

... further results

Experience reports

Annectdotal reports which describe this effect with our experience index include:

See also

External links

References

  1. 1.0 1.1 Papoutsis, Ioannis; Nikolaou, Panagiota; Stefanidou, Maria; Spiliopoulou, Chara; Athanaselis, Sotiris (2014). "25B-NBOMe and its precursor 2C-B: modern trends and hidden dangers". Forensic Toxicology. 33 (1): 1–11. doi:10.1007/s11419-014-0242-9. ISSN 1860-8965. 
  2. 2.0 2.1 Bersani, Francesco Saverio; Corazza, Ornella; Albano, Gabriella; Valeriani, Giuseppe; Santacroce, Rita; Bolzan Mariotti Posocco, Flaminia; Cinosi, Eduardo; Simonato, Pierluigi; Martinotti, Giovanni; Bersani, Giuseppe; Schifano, Fabrizio (2014). "25C-NBOMe: Preliminary Data on Pharmacology, Psychoactive Effects, and Toxicity of a New Potent and Dangerous Hallucinogenic Drug". BioMed Research International. 2014: 1–6. doi:10.1155/2014/734749. ISSN 2314-6133. 
  3. 3.0 3.1 Hartman, Alan M.; Hollister, Leo E. (1963). "Effect of mescaline, lysergic acid diethylamide and psilocybin on color perception". Psychopharmacologia. 4 (6): 441–451. doi:10.1007/BF00403349. ISSN 0033-3158. 
  4. 4.0 4.1 Kleinman, J. E.; Gillin, J. C.; Wyatt, R. J. (1977). "A Comparison of the Phenomenology of Hallucinogens and Schizophrenia From Some Autobiographical Accounts*". Schizophrenia Bulletin. 3 (4): 560–586. doi:10.1093/schbul/3.4.560. ISSN 0586-7614. 
  5. . doi:10.3389/Ffnhum.2015.00346.  Missing or empty |title= (help)
  6. Obreshkova, D., Kandilarov, I., Angelova, V. T., Iliev, Y., Atanasov, P., & Fotev, P. S. (2017). PHARMACO-TOXICOLOGICAL ASPECTS AND ANALYSIS OF PHENYLALKYLAMINE AND INDOLYLALKYLAMINE HALLUCINOGENS (REVIEW). PHARMACIA, 64(1), 41-42. http://bsphs.org/wp-content/uploads/2017/04/Angelova.pdf
  7. Abraham, Henry David (1983). "Visual Phenomenology of the LSD Flashback". Archives of General Psychiatry. 40 (8): 884. doi:10.1001/archpsyc.1983.01790070074009. ISSN 0003-990X. 
  8. Baggott, M.J.; Coyle, J.R.; Erowid, E.; Erowid, F.; Robertson, L.C. (2011). "Abnormal visual experiences in individuals with histories of hallucinogen use: A web-based questionnaire". Drug and Alcohol Dependence. 114 (1): 61–67. doi:10.1016/j.drugalcdep.2010.09.006. ISSN 0376-8716. 
  9. Dillon, P (2003). "Patterns of use and harms associated with non-medical ketamine use". Drug and Alcohol Dependence. 69 (1): 23–28. doi:10.1016/S0376-8716(02)00243-0. ISSN 0376-8716.